← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

F

$ Value

$40K

Shares

15,980

Price

$2

Filed

Feb 3

Insider

Name

Loerop James

Title

Chief Business Officer

CIK

0001781549

Roles

Officer

Transaction Details

Transaction Date

2025-02-01

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

102,773

Footnotes

The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4. | This amendment is being filed to correct the number of shares that were withheld by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units previously reported. This adjustment will affect the amount of securities beneficially owned following the reported transaction in subsequent filings.

Filing Info

Accession No.

0001781549-26-000005

Form Type

4/A

Issuer CIK

0001557746

Loerop James's History

Date Ticker Type Value
2026-02-03 ACRS M
2026-02-03 ACRS F $21K
2026-02-03 ACRS M $0
2026-02-02 ACRS A $0
2026-02-02 ACRS A $0
2026-02-01 ACRS M
2026-02-01 ACRS M
2026-02-01 ACRS M
2026-02-01 ACRS F $38K
2026-02-01 ACRS M $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02